Mumbai, Sept. 1 -- The stock debuted at Rs 978.20 on the BSE, a discount of 0.99% over its issue price.
So far, the stock has hit a high of Rs 1,021.95 and a low of Rs 933.80. On the BSE, over 6.87 lakh shares of the company were traded in the counter so far.
The initial public offer of Symbiotec Pharmalab was subscribed 71.26 times. The issue opened for bidding on 24 August 2026 and closed on 27 August 2026. The price band of the IPO was fixed between Rs 938 and 988 per share.
The IPO comprised a fresh issue of equity shares worth up to Rs 150 crore and an offer for sale aggregating up to Rs 1,607 crore by Satwani Holdings LLP, Rosewood Investments, and India Business Excellence Fund - III.
The objectives for the fresh issue includes R...